ArticleFrontiers in pharmacology2017
Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia
Abstract read
In one paragraph
Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Different domains of dengue research in the Philippines: A systematic review and meta-analysis of questionnaire-based studies.PloS one · 2021Pooled it
- Knowledge, attitude, and practice (KAP), and acceptance and willingness to pay (WTP) for mosquito-borne diseases control through sterile mosquito release in Bangkok, Thailand.PLoS neglected tropical diseases · 2025Article
- Estimating per-infection cost and burden for dengue and Zika as a function of antibody-dependent enhancement.PLoS neglected tropical diseases · 2025Article
- Users' Perceptions of Access to and Quality of Unified Health System Services in Brazil: A Cross-Sectional Study and Implications to Healthcare Management Challenges.International journal of environmental research and public health · 2024Article
- Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil.Journal of comparative effectiveness research · 2024Article
- Socioeconomic and fiscal returns of expanded investment in immunization: a case for life-course vaccination in Colombia.Health affairs scholar · 2024Article
- Dengue as a Disease Threatening Global Health: A Narrative Review Focusing on Latin America and Brazil.Tropical medicine and infectious disease · 2023Review
- Article
- An Asia-Pacific study on healthcare workers' perceptions of, and willingness to receive, the COVID-19 vaccination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
- Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh.Human vaccines & immunotherapeutics · 2021Article
- Hidden heterogeneity and its influence on dengue vaccination impact.Infectious Disease Modelling · 2020Article
- Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh.F1000Research · 2019Article
- Willingness to pay for an Ebola vaccine during the 2014-2016 ebola outbreak in West Africa: Results from a U.S. National sample.Human vaccines & immunotherapeutics · 2018Article
- Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties.Plant biotechnology journal · 2018Article
- Knowledge of Norovirus and Attitudes toward a Potential Norovirus Vaccine in Rural Guatemala: A Cross-Sectional Exploratory Survey.The American journal of tropical medicine and hygiene · 2018Article
- Customers' preferences and willingness to pay for a future dengue vaccination: a study of the empirical evidence in Vietnam.Patient preference and adherence · 2018Article
- The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study.Cost effectiveness and resource allocation : C/E · 2018Article
- Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.Frontiers in public health · 2018Review
- Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam.Patient preference and adherence · 2018Article
- Fighting the Dengue Virus.Cureus · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Isabella P GodóiPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil; SUS Collaborating Centre for Technology Assessment and Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil.
André S SantosPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Edna A ReisDepartment of Statistics, Exact Sciences Institute, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Livia L P LemosSUS Collaborating Centre for Technology Assessment and Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil; Programa de Pós-graduação em Saúde Pública, Faculdade de Medicina, Universidade Federal de Minas GeraisBelo Horizonte, Brazil.
Cristina M R BrandãoPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
Juliana AlvaresPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil; SUS Collaborating Centre for Technology Assessment and Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil.
Francisco A AcurcioPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil; SUS Collaborating Centre for Technology Assessment and Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil.
Brian GodmanStrathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde UniversityGlasgow, UK; Division of Clinical Pharmaclogy, Karolinska Institutet, Karolinska University HospitalStockholm, Sweden.
Augusto A Guerra JúniorPrograma de Pós-graduação em Medicamentos e Assistência Farmacêutica, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil; SUS Collaborating Centre for Technology Assessment and Excellence in Health, Faculdade de Farmácia, Universidade Federal de Minas GeraisBelo Horizonte, Brazil.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Brazilconsumersdenguevaccinewillingness to pay
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.